Hepion pharmaceuticals successfully completes application to the otcqb

Morristown, n.j., june 25, 2025 (globe newswire) -- hepion pharmaceuticals, inc. (otcqb:hepa), a clinical stage biopharmaceutical company that is developing and commercializing diagnostic tests for celiac disease, respiratory multiplex (covid/influenza a/b and rsv), helicobacter pylori (h.

HEPA Ratings Summary

HEPA Quant Ranking